Esprinet Balance Sheet Health
Financial Health criteria checks 4/6
Esprinet has a total shareholder equity of €389.2M and total debt of €119.2M, which brings its debt-to-equity ratio to 30.6%. Its total assets and total liabilities are €2.0B and €1.6B respectively. Esprinet's EBIT is €46.1M making its interest coverage ratio 3.2. It has cash and short-term investments of €216.4M.
Key information
30.6%
Debt to equity ratio
€119.16m
Debt
| Interest coverage ratio | 3.2x |
| Cash | €216.35m |
| Equity | €389.25m |
| Total liabilities | €1.63b |
| Total assets | €2.02b |
Recent financial health updates
Is Esprinet (BIT:PRT) A Risky Investment?
May 25
These 4 Measures Indicate That Esprinet (BIT:PRT) Is Using Debt Reasonably Well
Jan 11Esprinet (BIT:PRT) Has A Rock Solid Balance Sheet
Jul 27Does Esprinet (BIT:PRT) Have A Healthy Balance Sheet?
Mar 23Recent updates
Esprinet S.p.A.'s (BIT:PRT) CEO Might Not Expect Shareholders To Be So Generous This Year
Apr 11
Investments In AI And Solar Will Strengthen Future Prospects
Jan 19 Esprinet's growth in Solutions & Services outpaces market growth, highlighting potential for significant revenue and margin improvement in this high-margin segment.Why Esprinet's (BIT:PRT) Earnings Are Better Than They Seem
Sep 19Here's Why Shareholders Should Examine Esprinet S.p.A.'s (BIT:PRT) CEO Compensation Package More Closely
Apr 18Returns On Capital At Esprinet (BIT:PRT) Have Hit The Brakes
Aug 29Returns On Capital At Esprinet (BIT:PRT) Have Stalled
May 17Does Esprinet (BIT:PRT) Deserve A Spot On Your Watchlist?
Apr 26Esprinet S.p.A.'s (BIT:PRT) Intrinsic Value Is Potentially 73% Above Its Share Price
Mar 20What Is Esprinet S.p.A.'s (BIT:PRT) Share Price Doing?
Feb 23Returns On Capital Are Showing Encouraging Signs At Esprinet (BIT:PRT)
Nov 12Is It Time To Consider Buying Esprinet S.p.A. (BIT:PRT)?
Oct 20Here's Why We Think Esprinet (BIT:PRT) Might Deserve Your Attention Today
Sep 02What Does Esprinet S.p.A.'s (BIT:PRT) Share Price Indicate?
Jul 06Is Esprinet (BIT:PRT) A Risky Investment?
May 25At €10.74, Is Esprinet S.p.A. (BIT:PRT) Worth Looking At Closely?
Feb 24These 4 Measures Indicate That Esprinet (BIT:PRT) Is Using Debt Reasonably Well
Jan 11With EPS Growth And More, Esprinet (BIT:PRT) Is Interesting
Dec 14Esprinet (BIT:PRT) Hasn't Managed To Accelerate Its Returns
Nov 05Esprinet (BIT:PRT) Has A Rock Solid Balance Sheet
Jul 27Here's Why I Think Esprinet (BIT:PRT) Is An Interesting Stock
Jul 15Should You Think About Buying Esprinet S.p.A. (BIT:PRT) Now?
May 31Esprinet S.p.A. (BIT:PRT) Shares Could Be 29% Above Their Intrinsic Value Estimate
May 17I Ran A Stock Scan For Earnings Growth And Esprinet (BIT:PRT) Passed With Ease
Apr 05Does Esprinet (BIT:PRT) Have A Healthy Balance Sheet?
Mar 23How Does Esprinet S.p.A. (BIT:PRT) Fare As A Dividend Stock?
Mar 10Can You Imagine How Jubilant Esprinet's (BIT:PRT) Shareholders Feel About Its 155% Share Price Gain?
Feb 18How Much Of Esprinet S.p.A. (BIT:PRT) Do Insiders Own?
Feb 01Is It Too Late To Consider Buying Esprinet S.p.A. (BIT:PRT)?
Jan 18Esprinet S.p.A.'s (BIT:PRT) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 04
Financial Position Analysis
Short Term Liabilities: PRT's short term assets (€1.7B) exceed its short term liabilities (€1.4B).
Long Term Liabilities: PRT's short term assets (€1.7B) exceed its long term liabilities (€206.1M).
Debt to Equity History and Analysis
Debt Level: PRT has more cash than its total debt.
Reducing Debt: PRT's debt to equity ratio has increased from 27% to 30.6% over the past 5 years.
Debt Coverage: PRT's debt is not well covered by operating cash flow (2.3%).
Interest Coverage: PRT's interest payments on its debt are well covered by EBIT (3.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/08 03:45 |
| End of Day Share Price | 2025/05/08 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Esprinet S.p.A. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fabrizio Spagna | Axia Financial Research |
| Dino Catena | Equita SIM S.p.A. |
| Pietro Nargi | Intermonte SIM S.p.A. |